Insulin Analog [EPC]

183509 reported adverse events

Drugs of this class: INSULIN GLARGINE INSULIN LISPRO INSULIN DETEMIR INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 40915
1 BLOOD GLUCOSE DECREASED 10533
2 DRUG INEFFECTIVE 9335
3 NAUSEA 7979
4 DRUG DOSE OMISSION 6827
5 HYPOGLYCAEMIA 6755
6 INCORRECT DOSE ADMINISTERED 6330
7 MALAISE 5988
8 WEIGHT DECREASED 5464
9 VISUAL IMPAIRMENT 5077
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 146 0.9481
1 INTERCEPTED PRODUCT SELECTION ERROR 238 0.6667
2 ANTI-INSULIN ANTIBODY POSITIVE 111 0.5904
3 HYPOGLYCAEMIC UNCONSCIOUSNESS 842 0.5767
4 BLOOD KETONE BODY 107 0.5071
5 HYPOGLYCAEMIC SEIZURE 312 0.4720
6 SHOCK HYPOGLYCAEMIC 131 0.3887
7 ACCIDENTAL UNDERDOSE 603 0.3863
8 BLOOD GLUCOSE FLUCTUATION 2459 0.3784
9 DRUG ADMINISTERED IN WRONG DEVICE 94 0.3658
See all enriched reactions for Insulin Analog [EPC]